Maximilian Schmeding

Summary

Affiliation: University Hospital
Country: Germany

Publications

  1. ncbi request reprint Liver transplantation for intra- and extrahepatic cholangiocarcinoma
    Maximilian Schmeding
    Department of General, Visceral and Transplantation Surgery, University Hospital Aachen, RWTH Aachen, Germany
    Ann Transplant 18:1-8. 2013
  2. doi request reprint Mycophenolate mofetil monotherapy in liver transplantation: 5-year follow-up of a prospective randomized trial
    Maximilian Schmeding
    Department of General and Transplantation Surgery, University Hospital Aachen, RWTH Aachen, Germany
    Transplantation 92:923-9. 2011
  3. doi request reprint rHuEPo reduces ischemia-reperfusion injury and improves survival after transplantation of fatty livers in rats
    Maximilian Schmeding
    Department of General and Transplantation Surgery, Charité University Medical Centre Berlin, Campus Virchow Clinic, Berlin, Germany
    Transplantation 89:161-8. 2010
  4. doi request reprint ELISA-based detection of C4d after liver transplantation--a helpful tool for differential diagnosis between acute rejection and HCV-recurrence?
    Maximilian Schmeding
    Department of General, Visceral and Transplantation Surgery, Charite Campus Virchow Klinikum, Berlin, Germany
    Transpl Immunol 23:156-60. 2010
  5. ncbi request reprint Aging of the liver graft and functional quality in the absence of recurrent disease: a 10 year histological follow-up
    Maximilian Schmeding
    Department of General and Transplantation Surgery, Charite University Hospital Berlin, Campus Virchow Clinic, Augustenburger Platz 1, Berlin, Germany
    Ann Transplant 15:5-13. 2010
  6. doi request reprint Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection
    Marie Luise Berres
    Medical Department III, University Hospital Aachen, Aachen, Germany
    Hepatology 53:596-603. 2011
  7. ncbi request reprint Erythropoietin reduces ischemia-reperfusion injury after liver transplantation in rats
    Maximilian Schmeding
    Department of General and Transplantation Surgery, Charité University Medical Centre Berlin, Campus Virchow Clinic, 13353 Berlin, Germany
    Transpl Int 22:738-46. 2009
  8. ncbi request reprint Influence of basiliximab induction therapy on long term outcome after liver transplantation, a prospectively randomised trial
    Maximilian Schmeding
    Department of General and Transplantation Surgery, Charite Campus Virchow Klinikum, Berlin, Germany
    Ann Transplant 12:15-21. 2007
  9. ncbi request reprint Mycophenolate mofetil in liver transplantation--is monotherapy safe?
    Maximilian Schmeding
    Department of General and Transplantation Surgery, Charite Campus Virchow Klinikum, Berlin, Germany
    Clin Transplant 20:75-9. 2006
  10. ncbi request reprint Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases
    Ulf P Neumann
    Department of General, Visceral, and Transplantation Surgery, Universitatsklinikum Charite, Campus Virchow Klinikum, Humboldt Universitat, Berlin, Germany
    Surgery 146:52-9. 2009

Detail Information

Publications12

  1. ncbi request reprint Liver transplantation for intra- and extrahepatic cholangiocarcinoma
    Maximilian Schmeding
    Department of General, Visceral and Transplantation Surgery, University Hospital Aachen, RWTH Aachen, Germany
    Ann Transplant 18:1-8. 2013
    ..Modern, aggressive protocols of perioperative treatment have been established with promising results. This article provides an update and overview on the current status of LT as a potential option for patients with irresectable CCA. ..
  2. doi request reprint Mycophenolate mofetil monotherapy in liver transplantation: 5-year follow-up of a prospective randomized trial
    Maximilian Schmeding
    Department of General and Transplantation Surgery, University Hospital Aachen, RWTH Aachen, Germany
    Transplantation 92:923-9. 2011
    ..Mycophenolate mofetil (MMF) has proved to be a potent immunosuppressive agent free of the CNI-associated side effects...
  3. doi request reprint rHuEPo reduces ischemia-reperfusion injury and improves survival after transplantation of fatty livers in rats
    Maximilian Schmeding
    Department of General and Transplantation Surgery, Charité University Medical Centre Berlin, Campus Virchow Clinic, Berlin, Germany
    Transplantation 89:161-8. 2010
    ..Erythropoietin has been shown to reduce ischemia-reperfusion injury in transplanted rat livers. We investigated whether these capacities may contribute to improve marginal organ function...
  4. doi request reprint ELISA-based detection of C4d after liver transplantation--a helpful tool for differential diagnosis between acute rejection and HCV-recurrence?
    Maximilian Schmeding
    Department of General, Visceral and Transplantation Surgery, Charite Campus Virchow Klinikum, Berlin, Germany
    Transpl Immunol 23:156-60. 2010
    ..Consequently the role and potential value of C4d as a diagnostic marker may not be determined using ELISA-based tissue evaluation...
  5. ncbi request reprint Aging of the liver graft and functional quality in the absence of recurrent disease: a 10 year histological follow-up
    Maximilian Schmeding
    Department of General and Transplantation Surgery, Charite University Hospital Berlin, Campus Virchow Clinic, Augustenburger Platz 1, Berlin, Germany
    Ann Transplant 15:5-13. 2010
    ....
  6. doi request reprint Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection
    Marie Luise Berres
    Medical Department III, University Hospital Aachen, Aachen, Germany
    Hepatology 53:596-603. 2011
    ..001), whereas a level ≤ 220 pg/mL early after LT predicted the absence of F3 fibrosis during follow-up (P = 0.035)...
  7. ncbi request reprint Erythropoietin reduces ischemia-reperfusion injury after liver transplantation in rats
    Maximilian Schmeding
    Department of General and Transplantation Surgery, Charité University Medical Centre Berlin, Campus Virchow Clinic, 13353 Berlin, Germany
    Transpl Int 22:738-46. 2009
    ..Erythropoietin reduces ischemia-reperfusion injury after orthotopic liver transplantation in rats...
  8. ncbi request reprint Influence of basiliximab induction therapy on long term outcome after liver transplantation, a prospectively randomised trial
    Maximilian Schmeding
    Department of General and Transplantation Surgery, Charite Campus Virchow Klinikum, Berlin, Germany
    Ann Transplant 12:15-21. 2007
    ..It was the aim of this study to determine if Basilixirnab mduction therapy serves to reduce the incidence of acute rejection episodes and improves graft function and survival in the long term after OLT...
  9. ncbi request reprint Mycophenolate mofetil in liver transplantation--is monotherapy safe?
    Maximilian Schmeding
    Department of General and Transplantation Surgery, Charite Campus Virchow Klinikum, Berlin, Germany
    Clin Transplant 20:75-9. 2006
    ..This review provides an overview on the current role of MMF in immunosuppressive protocols after LTX and evaluates innovative therapeutic concepts...
  10. ncbi request reprint Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases
    Ulf P Neumann
    Department of General, Visceral, and Transplantation Surgery, Universitatsklinikum Charite, Campus Virchow Klinikum, Humboldt Universitat, Berlin, Germany
    Surgery 146:52-9. 2009
    ..The aim of the study was to identify risk factors for poor outcome in patients with pre-operative chemotherapy of CRM...
  11. ncbi request reprint Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients
    Maximilian Schmeding
    Department of General and Transplantation Surgery, Charite Campus Virchow Klinikum, Berlin, Germany
    Liver Transpl 13:687-92. 2007
    ..Patient and organ survival were similar when patients with large HCC and early tumor recurrence were excluded from analysis. LDLT can therefore be advocated for HCV patients...
  12. ncbi request reprint Erythropoietin promotes hepatic regeneration after extended liver resection in rats
    Maximilian Schmeding
    Department of General, Visceral and Transplantation Surgery at Charité, Campus Virchow Klinikum, Universitaetsmedizin Berlin, Germany
    J Gastroenterol Hepatol 23:1125-31. 2008
    ..To date, no data are available as to whether rHuEPO has the ability to stimulate liver regeneration after liver resection...